NCT06732492
- Conditions
- CART Therapy, CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies, Lymphoma, +6 more
- Locations
-
- Union Hospital Wuhan, Hubei, China
Clinical trial condition
Explore clinical trials studying NK T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
NCT06732492
NCT07639879
NCT07457177
Not specified
NCT07276737
Not specified
NCT07276698
Not specified
NCT02588651
NCT01445535